Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Nutritional interest of dietary fiber and prebiotics in obesity: Lessons from the MyNewGut consortium.

Delzenne NM, Olivares M, Neyrinck AM, Beaumont M, Kjølbæk L, Larsen TM, Benítez-Páez A, Romaní-Pérez M, Garcia-Campayo V, Bosscher D, Sanz Y, van der Kamp JW.

Clin Nutr. 2019 Mar 9. pii: S0261-5614(19)30115-3. doi: 10.1016/j.clnu.2019.03.002. [Epub ahead of print]

2.

The Potential Role of the Dipeptidyl Peptidase-4-Like Activity From the Gut Microbiota on the Host Health.

Olivares M, Schüppel V, Hassan AM, Beaumont M, Neyrinck AM, Bindels LB, Benítez-Páez A, Sanz Y, Haller D, Holzer P, Delzenne NM.

Front Microbiol. 2018 Aug 22;9:1900. doi: 10.3389/fmicb.2018.01900. eCollection 2018.

3.

Towards microbiome-informed dietary recommendations for promoting metabolic and mental health: Opinion papers of the MyNewGut project.

Sanz Y, Romaní-Perez M, Benítez-Páez A, Portune KJ, Brigidi P, Rampelli S, Dinan T, Stanton C, Delzenne N, Blachier F, Neyrinck AM, Beaumont M, Olivares M, Holzer P, Günther K, Wolters M, Ahrens W, Claus SP, Campoy C, Murphy R, Sadler C, Fernández L, Kamp JV.

Clin Nutr. 2018 Dec;37(6 Pt A):2191-2197. doi: 10.1016/j.clnu.2018.07.007. Epub 2018 Jul 9.

4.

The gut microbiota metabolite indole alleviates liver inflammation in mice.

Beaumont M, Neyrinck AM, Olivares M, Rodriguez J, de Rocca Serra A, Roumain M, Bindels LB, Cani PD, Evenepoel P, Muccioli GG, Demoulin JB, Delzenne NM.

FASEB J. 2018 Jun 15:fj201800544. doi: 10.1096/fj.201800544. [Epub ahead of print]

5.

The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice.

Olivares M, Neyrinck AM, Pötgens SA, Beaumont M, Salazar N, Cani PD, Bindels LB, Delzenne NM.

Diabetologia. 2018 Aug;61(8):1838-1848. doi: 10.1007/s00125-018-4647-6. Epub 2018 May 25.

6.

High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome.

Hassan AM, Mancano G, Kashofer K, Fröhlich EE, Matak A, Mayerhofer R, Reichmann F, Olivares M, Neyrinck AM, Delzenne NM, Claus SP, Holzer P.

Nutr Neurosci. 2018 Apr 26:1-17. doi: 10.1080/1028415X.2018.1465713. [Epub ahead of print]

PMID:
29697017
7.

Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: The PROFICEL study.

Olivares M, Benítez-Páez A, de Palma G, Capilla A, Nova E, Castillejo G, Varea V, Marcos A, Garrote JA, Polanco I, Donat E, Ribes-Koninckx C, Calvo C, Ortigosa L, Palau F, Sanz Y.

Gut Microbes. 2018 Nov 2;9(6):551-558. doi: 10.1080/19490976.2018.1451276. Epub 2018 May 9.

8.

Gut microbiota trajectory in early life may predict development of celiac disease.

Olivares M, Walker AW, Capilla A, Benítez-Páez A, Palau F, Parkhill J, Castillejo G, Sanz Y.

Microbiome. 2018 Feb 20;6(1):36. doi: 10.1186/s40168-018-0415-6.

9.

Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?

Cenit MC, Olivares M, Codoñer-Franch P, Sanz Y.

Nutrients. 2015 Aug 17;7(8):6900-23. doi: 10.3390/nu7085314. Review.

10.

Understanding the role of gut microbiome in metabolic disease risk.

Sanz Y, Olivares M, Moya-Pérez Á, Agostoni C.

Pediatr Res. 2015 Jan;77(1-2):236-44. doi: 10.1038/pr.2014.170. Epub 2014 Oct 14. Review.

PMID:
25314581
11.

Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease.

Olivares M, Castillejo G, Varea V, Sanz Y.

Br J Nutr. 2014 Jul 14;112(1):30-40. doi: 10.1017/S0007114514000609. Epub 2014 Apr 28.

PMID:
24774670
12.

Human milk composition differs in healthy mothers and mothers with celiac disease.

Olivares M, Albrecht S, De Palma G, Ferrer MD, Castillejo G, Schols HA, Sanz Y.

Eur J Nutr. 2015 Feb;54(1):119-28. doi: 10.1007/s00394-014-0692-1. Epub 2014 Apr 4.

PMID:
24700375
13.

Influence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study.

Pozo-Rubio T, de Palma G, Mujico JR, Olivares M, Marcos A, Acuña MD, Polanco I, Sanz Y, Nova E.

Nutr Hosp. 2013 Mar-Apr;28(2):464-73. doi: 10.3305/nh.2013.28.2.6310.

14.

Oral administration of Bifidobacterium longum CECT 7347 ameliorates gliadin-induced alterations in liver iron mobilisation.

Laparra JM, Olivares M, Sanz Y.

Br J Nutr. 2013 Nov;110(10):1828-36. doi: 10.1017/S0007114513001098. Epub 2013 May 9.

PMID:
23657133
15.

Host genotype, intestinal microbiota and inflammatory disorders.

Olivares M, Laparra JM, Sanz Y.

Br J Nutr. 2013 Jan;109 Suppl 2:S76-80. doi: 10.1017/S0007114512005521. Review.

PMID:
23360883
16.

Oral administration of Bifidobacterium longum CECT 7347 modulates jejunal proteome in an in vivo gliadin-induced enteropathy animal model.

Olivares M, Laparra M, Sanz Y.

J Proteomics. 2012 Dec 21;77:310-20. doi: 10.1016/j.jprot.2012.09.005. Epub 2012 Sep 27.

PMID:
23023000
17.

Immune development and intestinal microbiota in celiac disease.

Pozo-Rubio T, Olivares M, Nova E, De Palma G, Mujico JR, Ferrer MD, Marcos A, Sanz Y.

Clin Dev Immunol. 2012;2012:654143. Epub 2012 Sep 11. Review.

18.

Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model.

Laparra JM, Olivares M, Gallina O, Sanz Y.

PLoS One. 2012;7(2):e30744. doi: 10.1371/journal.pone.0030744. Epub 2012 Feb 10.

19.

Influence of Bifidobacterium longum CECT 7347 and gliadin peptides on intestinal epithelial cell proteome.

Olivares M, Laparra M, Sanz Y.

J Agric Food Chem. 2011 Jul 27;59(14):7666-71. doi: 10.1021/jf201212m. Epub 2011 Jun 22.

PMID:
21651295
20.

Heminephroureterectomy for duplex kidney: laparoscopy versus open surgery.

García-Aparicio L, Krauel L, Tarrado X, Olivares M, García-Nuñez B, Lerena J, Saura L, Rovira J, Rodo J.

J Pediatr Urol. 2010 Apr;6(2):157-60. doi: 10.1016/j.jpurol.2009.07.009. Epub 2009 Aug 12.

PMID:
19679515

Supplemental Content

Loading ...
Support Center